Genetic testing and genomic testing may sound similar, but they differ significantly in their scope and purpose, especially in the breast cancer space. ...

Patients with newly diagnosed, high-risk multiple myeloma experienced high rates of minimal residual disease (MRD) negativity with treatment with the ...

Scanxiety, a term often used to describe the anxiety associated with medical scans, extends beyond mere fear. It encompasses a spectrum of emotions that ...

Genomic testing plays a pivotal role in tailoring breast cancer treatment, particularly in the context of anti-estrogen therapy.As part of its Speaking Out ...

Preliminary results from a phase 3 trial determined that first line treatment with Lutathera (lutetium Lu 177-dotatate) improves progression-free survival ...

Breast cancer treatment, including the long-term use of anti-estrogen therapy, can bring about various side effects that patients should be aware of, ...

Determining the risk of breast cancer recurrence is a complex process involving both prognostic and predictive tools; however, outcomes can help patients ...

If you would like this piece read to you, just click above As things get more and more desperate in the cancer world the advertising for private ...

I love summer. I love fireflies and roses and front porches and ice cream. I love being outside every day, with endless choices of activities. I love the ...

Inflammatory breast cancer is a rare but aggressive type of breast cancer that is often confused with skin-related conditions because of its rash-like ...

The novel drug, mezigdomide, plus Velcade (bortezomib) and dexamethasone or Kyprolis (carfilzomib) and dexamethasone, led to promising responses in patients ...

“What stage is her cancer?” the woman next to me asked at the beauty parlor.“I think it’s two,” says another woman, one with foils in her hair.“Laura, you ...